Precigen (PGEN) Shares Outstanding (2011 - 2026)

Precigen (PGEN) has 16 years of Shares Outstanding data on file, last reported at $355.9 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $355.9 million, up 20.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $355.9 million (up 20.59% YoY), and the FY2025 annual result was $353.9 million, up 20.84% from the prior year.
• Shares Outstanding grew to $355.9 million in Q1 2026 per PGEN's latest filing, from $353.9 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $355.9 million in Q1 2026 and troughed at $207.7 million in Q1 2022.
• A 5-year average of $270.2 million and a median of $255.5 million in 2023 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding rose 23.18% in 2023, then slipped 2.05% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $208.2 million in 2022, then grew by 19.59% to $248.9 million in 2023, then advanced by 17.66% to $292.9 million in 2024, then increased by 20.84% to $353.9 million in 2025, then rose by 0.56% to $355.9 million in 2026.
• Business Quant data shows PGEN's Shares Outstanding at $355.9 million in Q1 2026, $353.9 million in Q4 2025, and $353.8 million in Q3 2025.